Okyanos Heart Institute Announces August Seminar to Discuss Coronary Artery Disease

Free Educational Seminar Led by Dr. Howard Walpole, Jr. Will Provide Information About New Cardiac Cell Therapy Treatment for Coronary Artery Disease

Freeport, Bahamas, The, August 16, 2012 --(PR.com)-- Okyanos Heart Institute (http://www.okyanos.com/), which brings a new standard of care and a better quality of life to patients with coronary artery disease (CAD) using cardiac cell therapy, has announced that it will host a free educational seminar led by Chief Medical Officer Howard Walpole, Jr., M.D., MBA, FACC, FACAI, FSCAI. During the seminar, Dr. Walpole will explain cardiac cell therapy and the potential benefits for individuals suffering from coronary artery disease. Interested individuals may attend the seminar on Wednesday, Aug. 29 from 2 p.m. to 4 p.m. or on Thursday, Aug. 30 from 2 p.m. to 4 p.m. at the Sheraton Jacksonville Hotel located at 10605 Deerwood Park Boulevard in Jacksonville, Fla. This seminar will provide information about a new treatment option to individuals who have exhausted conventional methods, such as stents and bypass surgery, yet continue to experience heart failure. Patients who have significant heart damage as a result of one or more heart attacks are also invited to attend. Complimentary hors d’oeuvres and beverages will be served.

Individuals interested in attending can RSVP toll-free by phone at 1-855-659-6790 or online at http://okyanos.com/seminars. Seats are limited.

“Okyanos Heart Institute looks forward to educating the public on the latest advances in cardiac cell therapy and how it can deliver a better quality of life to patients suffering from coronary artery disease,” said Matthew Feshbach, co-founder and CEO of Okyanos Heart Institute. “Dr. Walpole, a leading expert cardiologist, will explain the science behind stem cell medicine and the five day Okyanos treatment, helping patients find the care that will best address their individual medical needs.”

“I am eager to provide information about the Okyanos cardiac cell therapy treatment and discuss the science and data behind stem and regenerative cell therapy,” said Walpole. “There are many individuals suffering from coronary artery disease who are unaware of treatment options available to them, and I look forward to this interactive seminar where people have the opportunity to ask questions and receive the answers that can put them on the path to an improved life with a healthier heart.”

New Media Content:
Okyanos LinkedIn page:

Okyanos Facebook page:

Okyanos Twitter page:

About Okyanos Heart Institute:
Based in Freeport, the Bahamas, the Okyanos Heart Institute is a Center of Excellence (CoE) adhering to U.S. surgical center standards and led by Chief Medical Officer Howard T. Walpole Jr., M.D., MBA, FACC, FACAI, FSCAI, a leader of the American College of Cardiology for many years. The mission of Okyanos Heart Institute is to bring a new standard of care and a better quality of life to patients with chronic coronary artery disease using cardiac cell therapy. The Okyanos treatment utilizes cardiac cell therapy, a unique blend of stem and regenerative cells to support the growth of new blood vessels and to assist the heart in repairing tissue damaged by heart attack and disease. The Greek god of rivers, “Okyanos” symbolizes the primary mechanism of action that these adult stem cells have on ischemic (lack of blood flow) heart tissue, the result of the plaque deposits in the coronary arteries. The stem cells, derived from a person’s adipose (fat) tissue, create new blood vessels, a process known as angiogenesis. These cells facilitate blood flow in the heart and intake and use of oxygen, as measured by a rigorous clinical trial known as the PRECISE trial, as well as cardiac cell therapy trials at leading research institutions. For more information, visit http://www.okyanos.com/.

Anjelica Cummings
MMI Public Relations
(919) 233-6600
Okyanos Heart Institute
Patty Briguglio